We are live on ! Find out more

11 hedge funds and large institutions have $956K invested in Imunon in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.04% less ownership

Funds ownership: 0.08%0.04% (-0.04%)

25% less capital invested

Capital invested by funds: $1.28M → $956K (-$321K)

27% less funds holding

Funds holding: 1511 (-4)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
11
Holders Change
-4
Holders Change %
-26.67%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
5
Closed
4
Calls
Puts
Net Calls
Net Calls Change

IMNN Hedge Fund Activity: Q3 2017 in Review

11 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2017, worth a combined $956K — down 25% from $1.28M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IMNN and 1 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $147K. The largest seller was Sabby Management, cutting an estimated $65K.

  • 11 institutional investors held Imunon (IMNN) as of Q3 2017, down from 15 in Q2 2017.
  • Funds reported $956K of Imunon stock for Q3 2017, down 25% quarter-over-quarter.
  • 1 fund opened new Imunon positions in Q3 2017 and 4 closed out, a net change of -3 holders.
  • The largest Imunon buyer in Q3 2017 was Renaissance Technologies, an estimated $147K added.
  • The largest Imunon seller in Q3 2017 was Sabby Management, an estimated $65K sold.

Based on aggregated 13F filings for Q3 2017.